A bid by German drug giant Bayer's, to block a generic version of its blockbuster cancer treatment Nexavar by a local drug maker was rejected by the Indian court on Saturday, which was a move hailed by activists. The judges rejected an appeal by Bayer on Friday that contested a March 2012 decision by India's patent controller, who had argued the price charged by Bayer for the liver and kidney drug, (Dollar) 5,500-per-person, per month in India was far too costly for most ...Sunday 14 December 2014
Indian Court Rejects German Drug Giant's Bid With Public Health Interests in Mind
A bid by German drug giant Bayer's, to block a generic version of its blockbuster cancer treatment Nexavar by a local drug maker was rejected by the Indian court on Saturday, which was a move hailed by activists. The judges rejected an appeal by Bayer on Friday that contested a March 2012 decision by India's patent controller, who had argued the price charged by Bayer for the liver and kidney drug, (Dollar) 5,500-per-person, per month in India was far too costly for most ...
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment